|Bid||0.00 x 1200|
|Ask||0.00 x 800|
|Day's Range||22.31 - 22.79|
|52 Week Range||19.63 - 30.10|
|Beta (3Y Monthly)||0.07|
|PE Ratio (TTM)||7.65|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Total Revenues – Net, increased 6% to $41.9 million, for the six month period ended December 31, 2018, versus same six month period during prior year.Income from Operations.
NEW YORK, Feb. 05, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
FONAR Corporation (NASDAQ-FONR), Inventor of MR Scanning™, reported that its founder, chairman of the board and past president, Raymond V. Damadian, M.D. received the Excellence in Medicine award from the Chiari & Syringomyelia Foundation (CSF), on November 10, 2018, at Brooks’s, London, England. Dr. Damadian was introduced by Fraser C. Henderson, Sr., M.D., a neurosurgeon and a member of the steering committee for the Chiari & Syringomyelia Foundation and Professor Donlin Long, M.D., former Chairman of Neurosurgery at Johns Hopkins University.